Circulating levels of CD11b+ myeloid cells were increased after MI and were not affected by ACE-I treatment; interestingly, the number of circulating Ly6Chigh monocytes was statistically significantly lower in the treatment group post-MI (Figure 2A). Here, ITGAM is linked to myocardial infarction.